REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
https://www.ispor.org/heor-resources/presentations-database/presentation/intl2023-3669/124900
 
Devine F1; Clary A2; Liu JH1; Wu YC1; Park J3; Bhat A2
 
Mar 9, 2023
 
Prev Next